Condition
Episodic Migraine clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Episodic Migraine clinical trials that are recruiting, at sites in 30 countries (most in Italy (5), United States (5), Spain (4)). By phase: Phase 3 (3), Phase 2 (2). The most active sponsors are Hospital Universitari Vall d'Hebron Research Institute (2), AbbVie (2). There are also 1 NIH-funded research project on Episodic Migraine, with $535,738 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 1NIH research projects
- 30Countries
Newest Episodic Migraine clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Gou-Teng-San (GTS) for adults with episodic migraine | Phase 3 | Taichung, South | Recruiting | Mar 27, 2026 |
| Real-world use of anti-CGRP medicines for preventing migraine | — | Miami, Florida and 25 other locations | Recruiting | Sep 8, 2025 |
| i-NEED: New migraine drugs database | — | Milan, Italy and 1 other locations | Recruiting | Aug 5, 2025 |
| Effects of Atogepant on Neurophysiology and Biomolecules in Migraine | — | Pavia, PAVIA | Recruiting | Mar 18, 2025 |
| Analyzing CGRP Levels in Migraine Patients by Age and Sex | — | Barcelona, Barcelona | Recruiting | Nov 5, 2024 |
| Assessing the safety and effectiveness of Atogepant for migraine prevention in Korean adults | — | Busan, Busan Gwang Yeogsi and 35 other locations | Recruiting | Sep 19, 2024 |
| Using Atorvastatin to prevent episodic migraines | Phase 2 | Bergen and 5 other locations | Recruiting | Feb 8, 2024 |
| Chiropractic care to reduce episodic migraine attacks. | — | Boston, Massachusetts | Recruiting | Jan 29, 2024 |
| Eptinezumab for treating episodic migraine in children | Phase 3 | Stamford, Connecticut and 59 other locations | Recruiting | Jun 9, 2023 |
| Blocking scalp nerves to treat episodic migraines | Phase 2 | Rochester, Minnesota | Recruiting | Feb 21, 2023 |
All recruiting trials (12)
-
Gou-Teng-San (GTS) for adults with episodic migraine
This trial will test whether the herbal formula Gou-Teng-San (GTS) can reduce migraine attacks and symptoms in adults with episodic migraine.
-
Real-world use of anti-CGRP medicines for preventing migraine
This project will follow people with episodic or chronic migraine who start anti-CGRP medicines to see if the treatments reduce migraine frequency and side effects over two years.
-
i-NEED: New migraine drugs database
This project will collect real-life data to see how new migraine treatments—anti‑CGRP antibodies, gepants, ditans, and a sumatriptan‑naproxen combo—work and how well adults with episodic or chronic migraine tolerate them.
-
Effects of Atogepant on Neurophysiology and Biomolecules in Migraine
This study is testing if a new migraine medication called atogepant can change brain activity and biochemistry in people who have frequent migraines.
-
Analyzing CGRP Levels in Migraine Patients by Age and Sex
This study looks at the levels of a substance linked to migraines in people with migraines and healthy individuals to see how age and sex might affect treatment responses.
-
Assessing the safety and effectiveness of Atogepant for migraine prevention in Korean adults
This study is testing how well and safely Atogepant works for preventing migraines in Korean adults who have chronic or episodic migraines.
-
Using Atorvastatin to prevent episodic migraines
This study is testing whether taking Atorvastatin can help people who get frequent migraines have fewer attacks each month.
-
Chiropractic care to reduce episodic migraine attacks.
This pilot will test whether a 14-visit chiropractic care program, compared with headache health education plus usual care, can reduce migraine days and severity in adults with episodic migraine.
-
Eptinezumab for treating episodic migraine in children
This study tests if a new medication called eptinezumab can help reduce the number of migraine days in children who have episodic migraines.
-
Blocking scalp nerves to treat episodic migraines
This study is testing if blocking certain scalp nerves with a combination of medication can help people with episodic migraines feel better and have fewer headaches.
-
Assessing Atogepant for Treating Pediatric Migraines
This study is testing if Atogepant tablets can help children aged 6 to 17 with migraines feel better by reducing how often and how badly their headaches happen.
-
Understanding how CGRP affects autonomic function in migraine patients
This study is trying to see how a migraine treatment affects the nervous system in people with migraines, both during attacks and when they're feeling fine.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Chiropractic care for reducing migraine frequency and severity
This study is looking at how well chiropractic care can help adult women with occasional migraines by trying out a special treatment plan over several visits to see if it can make their headaches less frequent and less painful.
Related topics
Quick answers
How many Episodic Migraine clinical trials are recruiting right now?
12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 30 countries. The most sites are in Italy (5 trials), United States (5 trials), Spain (4 trials), Poland (3 trials), Argentina (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.